Latest News and Press Releases

Kaerus announces its novel BK channel modulator KER-0193 is safe and well tolerated in Phase 1, also demonstrating proof of mechanism with EEG biomarker.

Kaerus announces its novel BK channel modulator KER-0193 is safe and well tolerated in Phase 1, also demonstrating proof of mechanism with EEG biomarker.

SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2024 financial results on Thursday, February 20,...

Dr. Nader, current Independent Board Director at Moderna and Senior Advisor at Blackstone Life Sciences, joins GEn1E Lifesciences board as chair.

Cheyenne, Wyoming, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Cask Cartel  As the holiday season approaches, Cask Cartel, the Largest Fine & Rare Spirits Marketplace, is thrilled to announce exclusive...

CORAL GABLES, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...

CELEBRATION, Fla., July 30, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company) a rare disease therapeutics company, today announced that it will host a...

FSR Launches Say Sarcoidosis campaign for April's Awareness Month

MONTRÉAL, 19 mars 2024 (GLOBE NEWSWIRE) -- Ressources Géoméga Inc. (« Géoméga » ou la « Société ») (TSX.V: GMA) (OTC: GOMRF), développeur de technologies propres et alternatives pour...

MONTREAL, March 19, 2024 (GLOBE NEWSWIRE) -- Geomega Resources Inc. (“Geomega” or the “Corporation”) (TSX.V: GMA) (OTC: GOMRF), a developer of clean technologies for the mining, refining, and...